Remission InductionRemission, SpontaneousDiabetes Mellitus, Type 1Diabetes MellitusDiabetes Mellitus, Type 2Diabetes ComplicationsTreatment OutcomeDiabetes Mellitus, ExperimentalRecurrenceFollow-Up StudiesTime FactorsCytarabineAntineoplastic Combined Chemotherapy ProtocolsBlood GlucoseDiabetes, GestationalLeukemia, Myeloid, AcuteCyclophosphamideCombined Modality TherapyHemoglobin A, GlycosylatedVincristineHypoglycemic AgentsPrednisonePrecursor Cell Lymphoblastic Leukemia-LymphomaPrognosisRisk FactorsPrednisoloneInsulinProspective StudiesMethotrexateRetrospective StudiesDrug Therapy, CombinationDaunorubicinTransplantation, AutologousImmunosuppressive AgentsAntineoplastic AgentsDrug Administration ScheduleDiabetes InsipidusDisease-Free SurvivalBone Marrow TransplantationSeverity of Illness IndexAntirheumatic AgentsLeukemia, LymphoidSurvival AnalysisDoxorubicinAcute DiseaseLeukemia, MyeloidNephrotic SyndromeMesalamineNeoplasm, ResidualColitis, UlcerativeThioguanineCohort StudiesHematopoietic Stem Cell TransplantationEtoposideAntibodies, Monoclonal, Murine-DerivedBone MarrowSurvival RateAntibodies, MonoclonalTransplantation, HomologousHyperglycemiaHodgkin DiseaseDose-Response Relationship, DrugLeukemiaDisease ProgressionArthritis, RheumatoidAsparaginase6-MercaptopurineLeukemia, Promyelocytic, AcuteCrohn DiseaseLymphoma, Non-HodgkinIdarubicinGlucose Tolerance TestSalvage TherapyDepressive Disorder, MajorDiabetic NephropathiesBiological MarkersIslets of LangerhansGlucocorticoidsPrevalenceAge FactorsDouble-Blind MethodMice, Inbred NODCase-Control StudiesObesityAnti-Inflammatory AgentsInsulin ResistanceInsulin-Secreting CellsPrediabetic StatePredictive Value of TestsPituitary ACTH HypersecretionAzathioprineMelphalanMechlorethamineBleomycinDiabetic RetinopathyClinical Trials as TopicPilot ProjectsLongitudinal StudiesWegener GranulomatosisAdministration, Oral